United Therapeutics Corp (NASDAQ:UTHR) - Share price - Overview

Stock Report

United Therapeutics Corp UTHR

Last Price
$117.57

Day Change
0.04|0.03%

As of 20/09/2017
17:31:21 EDT | USD
Minimum 15 Minutes Delay.

Last Close117.53
Day Range117.07 - 118.52
Mkt Cap5.11Bil
52-Wk Range110.90 - 169.89
Yield %-
ISINUS91307C1027
Volume488,291
P/E13.53
P/S3.29
P/CF7.75

Share Price

Financials
201420152016
More ...
Income Statement
Revenue1,288.521,465.761,598.80
Operating Income538.80699.021,061.70
Net Income340.07651.64713.70
Basic EPS7.0614.1716.29
Avg. Diluted Shares Outstanding545147
Balance Sheet
Current Assets974.201,275.341,424.80
Non Current Assets910.21909.11900.80
Total Assets1,884.412,184.452,325.60
Current Liabilities504.31440.82332.50
Total Liabilities642.05595.89474.30
Total Equity1,242.361,588.551,851.30
Cash Flow
Operating Cash Flow355.26382.76643.60
Capital Expenditure-47.44-49.79-43.20
Free Cash Flow307.82332.97600.40

In millions, except "Basic EPS". Currency is USD.

Company Profile

United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

750
Key Stats
More ...
Price/Earning TTM12.82
Price/Book2.87
Price/Sales TTM3.29
Rev Growth (3 year avg)12.70
EPS Growth (3 year avg)-
Operating Margin % TTM66.41
Net Margin % TTM44.64
ROE TTM41.50
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.